Yidu Technology (02158) has been repurchased 11 times since December, with multiple international approvals showing confidence in development

The Zhitong Finance App learned that on December 19, Yidu Technology (02158) announced that 93,500 shares were repurchased at a price of HK$5.23 per share on the same day, with a repurchase amount of about HK$490,000. Since December, the company has repurchased 11 times, with a total repurchase of about 3.44 million shares, with a total amount exceeding HK$17.4 million. Continuing to strengthen market confidence with real money, demonstrating Yidu Technology's firm optimism about its own development prospects.

In terms of news, Yidu Technology has been spreading rapidly recently in the field of industry recognition and international cooperation. At the annual conference of the Digital Medicine Research Institute of the City University of Hong Kong, Ms. Gong Rujing, the founder and chairman of the company, was hired as a member of the Institute's advisory committee, demonstrating the industry's recognition and trust in Yidu Technology and the strategic leader of Ms. Gong Rujing in the field of AI medicine.

At the same time, it is worth noting that Yidu Technology has achieved an important breakthrough in the international multilateral cooperation arena: the Shanghai Cooperation Organization National Multi-functional Economic and Trade Platform (SCO Homeland) Health Sustainability Working Committee was recently formally established, and Yidu Technology was successfully selected as a member unit of the organization; Xu Jiming, the company's co-founder and CEO, was elected as the first member of the committee. The double recognition marks that the company's professional ability and industry position in the field of international digital health cooperation have received authoritative endorsement.

In recent years, Yidu Technology's international strategic layout has progressed steadily, and its business and customer network have expanded to six regions around the world. Through deep collaboration with local government departments, medical institutions and research institutes, we have built a mature localized cooperative ecosystem. The intelligent solutions developed have been widely implemented in key fields such as infectious disease monitoring and early warning, national population health management, AI-assisted diagnosis and treatment, and personalized health management, and continue to empower the development of global health services with scientific and technological strength.